Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
14
03
2021
accepted:
25
05
2021
entrez:
10
6
2021
pubmed:
11
6
2021
medline:
12
11
2021
Statut:
epublish
Résumé
Colorectal cancer (CRC) is one of the leading causes of cancer death worldwide. There is an urgent need to identify prognostic markers for patients undergoing curative resection of CRC. The detection of circulating tumor cells in peripheral blood is a promising approach to identify high-risk patients with disseminated disease in colorectal cancer. This study aims to evaluate the prognostic relevance of preoperative CTCs using the Cellsearch® system (CS) in patients, who underwent resection with curative intent of different stages (UICC I-IV) of colorectal cancer. Out of 91 Patients who underwent colorectal resection, 68 patients were included in this study. CTC analysis was performed in patients with CRC UICC stages I-IV immediately before surgery. Data were correlated with clinicopathological parameters and patient outcomes. One or more CTCs/7.5 mL were detected in 45.6% (31/68) of patients. CTCs were detected in all stages of the Union of International Cancer Control (UICC), in stage I (1/4, 25%), in stage II (4/12, 33.3%), in stage III (5/19, 26.3%) and in stage IV (21/33, 63.6%). The detection of ≥ 1 CTCs/ 7.5ml correlated to the presence of distant overt metastases (p = 0.014) as well as with shorter progression-free (p = 0.008) and overall survival (p = 0.008). Multivariate analyses showed that the detection of ≥ 1 CTCs/ 7.5ml is an independent prognostic indicator for overall survival (HR, 3.14; 95% CI, 1.18-8.32; p = 0.021). The detection of CTCs is an independent and strong prognostic factor in CRC, which might improve the identification of high-risk patients in future clinical trials.
Identifiants
pubmed: 34111181
doi: 10.1371/journal.pone.0252897
pii: PONE-D-21-08416
pmc: PMC8191913
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0252897Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Crit Rev Oncol Hematol. 2013 Nov;88(2):338-56
pubmed: 23830807
Cancer Discov. 2021 Apr;11(4):858-873
pubmed: 33811121
Adv Drug Deliv Rev. 2018 Feb 1;125:102-121
pubmed: 29355669
Cancers (Basel). 2019 Mar 21;11(3):
pubmed: 30901891
Oncol Res Treat. 2017;40(7-8):417-422
pubmed: 28693013
N Engl J Med. 2004 Aug 19;351(8):781-91
pubmed: 15317891
Clin Cancer Res. 2008 Oct 1;14(19):6302-9
pubmed: 18829513
Clin Colon Rectal Surg. 2017 Nov;30(5):324-332
pubmed: 29184467
Asia Pac J Clin Oncol. 2019 Jun;15(3):136-143
pubmed: 30761750
Clin Cancer Res. 2004 Oct 15;10(20):6897-904
pubmed: 15501967
Clin Cancer Res. 2007 Feb 1;13(3):920-8
pubmed: 17289886
Ann Surg Oncol. 2018 Jun;25(6):1454-1455
pubmed: 29616422
Sci Transl Med. 2016 Jul 6;8(346):346ra92
pubmed: 27384348
J Cancer Res Clin Oncol. 2013 Aug;139(8):1411-6
pubmed: 23736274
Nat Rev Cancer. 2003 Jun;3(6):453-8
pubmed: 12778135
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
J Cancer. 2014 Mar 15;5(4):262-71
pubmed: 24790654
Acta Cytol. 2019;63(6):479-488
pubmed: 30783027
Proc Natl Acad Sci U S A. 1979 Mar;76(3):1438-42
pubmed: 286328
BMC Cancer. 2015 Mar 30;15:202
pubmed: 25880692
Ann Oncol. 2013 Oct;24 Suppl 6:vi64-72
pubmed: 24078664
BMJ Open. 2013 Sep 10;3(9):e003055
pubmed: 24022388
Breast Cancer Res. 2014 Sep 16;16(5):440
pubmed: 25223629
Hum Pathol. 2004 Jan;35(1):122-8
pubmed: 14745734
BMC Cancer. 2012 May 16;12:178
pubmed: 22591372
Colorectal Dis. 2009 May;11(4):354-64; discussion 364-5
pubmed: 19016817
Adv Clin Exp Med. 2016 Nov-Dec;25(6):1273-1279
pubmed: 28028983
Z Gastroenterol. 2013 Aug;51(8):753-854
pubmed: 23955142
Ann Surg Oncol. 2010 Jun;17(6):1471-4
pubmed: 20180029
J Clin Oncol. 2008 Jul 1;26(19):3213-21
pubmed: 18591556
Surg Endosc. 2018 Dec;32(12):5021-5030
pubmed: 30324463
Nat Cell Biol. 2009 Feb;11(2):162-71
pubmed: 19136966
Clin Colorectal Cancer. 2018 Sep;17(3):e569-e577
pubmed: 29980491
Cancers (Basel). 2019 Jul 24;11(8):
pubmed: 31344798
BMC Cancer. 2017 Nov 7;17(1):725
pubmed: 29115932
Ann Surg. 2015 Jan;261(1):164-71
pubmed: 24509211
Br J Cancer. 2015 Apr 14;112(8):1306-13
pubmed: 25867263
Minim Invasive Ther Allied Technol. 2016 Oct;25(5):226-33
pubmed: 27415777
J Zhejiang Univ Sci B. 2009 Mar;10(3):219-29
pubmed: 19283877